ArticleJournal of immunotherapy (Hagerstown, Md. : 1997)

Immune-Related Adverse Events Among Patients With Endometrial Cancer Receiving Pembrolizumab Alone or With Other Treatments: A Single-Center Real-World Experience.

Glenn Boyles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.